Streetbeat News

Analyst Ratings

DH

Stifel analyst David Grossman has maintained a Buy rating on Definitive Healthcare (NASDAQ:DH) but has reduced the price target from $12 to $11 as reported on January 16, 2024.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 3:26 pm

PLXS

Benchmark analyst David Williams has reiterated a Buy rating on Plexus (NASDAQ:PLXS) and maintained a price target of $110. This reaffirmation of confidence in Plexus's stock performance could influence investor sentiment and potentially impact the stock's short-term price movement.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 3:24 pm

BC

Stifel analyst Drew Crum has reaffirmed a Buy rating on Brunswick Corporation (NYSE:BC) and increased the price target from $88 to $97, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 3:24 pm

SAP

Goldman Sachs analyst Mohammed Moawalla has reaffirmed a Buy rating on SAP (NYSE:SAP) and increased the price target from $168 to $185, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 3:21 pm

CASY

Benchmark analyst John Lawrence has reiterated a Buy rating on Casey's General Stores (NASDAQ:CASY) and maintained a price target of $312.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 3:21 pm

ZTS

Goldman Sachs analyst Nathan Rich has reaffirmed a Buy rating on Zoetis (NYSE:ZTS) and increased the price target from $190 to $226, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 3:20 pm

DFS

Discover Financial Services (NYSE:DFS) is set to release its Q4 earnings after market close on Jan. 17, 2023. Analysts predict a decrease in earnings per share to $2.51 from $3.77 year-over-year, but an increase in revenue to $4.10 billion from $3.73 billion. The company is considering the sale of its Discover Student Loans portfolio. Recent analyst ratings have varied, with price targets ranging from $99 to $133. DFS shares slightly rose by 0.1% to close at $109.66 on Tuesday.

Portfolio Pulse from Avi Kapoor

January 17, 2024 | 3:20 pm

IDXX

Goldman Sachs analyst Nathan Rich has reaffirmed a Buy rating on IDEXX Laboratories (NASDAQ:IDXX) and increased the price target from $500 to $650.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 3:18 pm

ELAN

Goldman Sachs analyst Nathan Rich has maintained a Sell rating on Elanco Animal Health (NYSE:ELAN) but increased the price target from $10 to $12.5.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 3:17 pm

AMX

Goldman Sachs analyst Diego Aragao has maintained a Neutral rating on America Movil (NYSE:AMX) and increased the price target from $19 to $20.

Portfolio Pulse from Benzinga Newsdesk

January 17, 2024 | 3:11 pm